Dr. Michael L. Stanchina, MD

Dr. Stanchina practices at Kent Hospital in Warwick, Rhode Island, part of Care New England Health System.

Dr. Stanchina's NPI, 1518989367, was assigned on July 24, 2006. Dr. Stanchina graduated from West Virginia University School of Medicine in 1994. Dr. Stanchina holds Massachusetts license 154510.

Dr. Stanchina's primary practice is Kent Hospital, at 455 Toll Gate Rd, Warwick, RI 02886 in Kent County. The practice phone is (401) 737-7010.

Dr. Stanchina's primary practice is Kent Hospital in Warwick, Rhode Island, part of Care New England Health System. Dr. Stanchina is also affiliated with The Miriam Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Stanchina to 4 more hospitals, 8 medical groups, 3 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stanchina practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Stanchina's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Stanchina's licenses on file in 2 states: Massachusetts and Rhode Island.

CMS data shows 1,493 Medicare services from Dr. Stanchina across 13 procedure codes in 2024, for 908 Medicare patients. Medicare paid $121,711 for them.

CMS counts 908 Medicare patients who saw Dr. Stanchina in 2024. The largest group is 75 to 84, with 413 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stanchina's median patient age at 70, with 55% women.

In 2024, Dr. Stanchina wrote 4,013 Medicare Part D claims for 628 patients. CMS names the drug for 3,755 of them, across 48 drugs with 11 or more claims each, at $1,531,884 in total drug cost. In 2023, CMS named 2,802 claims across 46 drugs.

Dr. Stanchina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stanchina as offering telehealth.

Dmand AI links 7 papers to Dr. Stanchina, published from 2005 to 2013. The most frequent topics are Continuous Positive Airway Pressure, Sleep Apnea, Obstructive and Patient Compliance. Dr. Stanchina has published most often in J Clin Sleep Med. Dr. Stanchina's most frequent co-authors are Atul Malhotra, MD, William M. Corrao, MD and Elias J. Jabbour, MD.

CMS Open Payments shows 593 general payments to Dr. Stanchina from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 86% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $78,086.

Dr. Stanchina graduated from West Virginia University School of Medicine in 1994.